Cardiologist at Heart House NJ
- Customer assessment of Edwards Lifesciences' (NYSE: EW) vs Medtronic's (NYSE: MDT) vs Boston Scientific's (NYSE: BSX) TAVR (transcatheter aortic valve replacement) offerings vs surgical valve by patient risk and age
- patient risk and age 2. Clinical advantages of Abbott's (NYSE: ABT) Portico minimally invasive FlexNav delivery system and potential pricing’s impact on uptake
- Abbott's recent European launch of its newer-generation Navitor TAVR implant and FDA approval outlook
- Pacemaker rate concerns around the Navitor
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.